Toxic Shock and Shock-Like Syndrome: The Constant Threat

Fadi Al Akhrass, Lina Abdallah, Alaa Hrizat and Shumaila Hanif

Department of Infectious Diseases and Infection Control, Pikeville Medical Center, USA
Department of Basic Sciences, University of Pikeville, Kentucky College of Osteopathic Medicine, USA

^*Correspondance to: Fadi Al Akhrass 

 PDF  Full Text DOI: 10.25107/2474-1647.2619

Abstract

We present a case of concomitant Streptococcus pyogenes (GAS; Group A Streptococcus) and Methicillin-Resistant Staphylococcus Aureus (MRSA) Toxic Shock Syndrome (TSS) who responded to conservative therapy with adjunctive Intravenous Immunoglobulin (IVIG) and Hyperbaric Oxygen (HBO) therapy. TSS is a devastating illness with a high mortality rate; therefore, we stress the importance of early multidisciplinary approaches including early administration of IVIGT and HBOT.

Keywords

Cite the article

Al Akhrass F, Abdallah L, Hrizat A, Hanif S. Toxic Shock and Shock-Like Syndrome: The Constant Threat. Clin Surg. 2019; 4: 2619.